Newer Generation Fentanyl Transmucosal Products for Breakthrough Pain in Opioid-Tolerant Cancer Patients

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.9, 2011-09, pp. : 605-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fentanyl Buccal Tablet: In Breakthrough Pain in Opioid-Tolerant Patients with Cancer

By Blick Stephanie K.A. Wagstaff Antona J.

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2387-2393

Adis International

Access to resources Recommend Favorite

Fentanyl Sublingual: In Breakthrough Pain in Opioid-Tolerant Adults with Cancer

By Chwieduk Claudine M. McKeage Kate

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2281-2288

Adis International

Access to resources Recommend Favorite

Fentanyl Pectin Nasal Spray: In Breakthrough Pain in Opioid-Tolerant Adults with Cancer

By Lyseng-Williamson Katherine A.

CNS Drugs, Vol. 25, Iss. 6, 2011-06 ,pp. : 511-522

Adis International

Access to resources Recommend Favorite

Fentanyl Buccal Tablet in Breakthrough Pain in Opioid-Tolerant Patients with Cancer: A Viewpoint by Donald R. Taylor

By Taylor Donald R.

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2394-2395

Adis International

Access to resources Recommend Favorite

Fentanyl pectin nasal spray: a guide to its use in breakthrough pain in opioid-tolerant adults with cancer

By Lyseng-Williamson Katherine A.

Drugs & Therapy Perspectives, Vol. 28, Iss. 1, 2012-01 ,pp. : 6-10

Adis International

Access to resources Recommend Favorite